SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wanbury - Quaterly Results

07 Jul 2023 Evaluate
The revenue for the March 2023 quarter is pegged at Rs. 1329.75 millions against Rs. 1343.94 millions recorded during the year-ago period.Net profit was down at Rs. 10.15  millions against Rs. 825.45 millions recorded in the corresponding quarter a year ago.The net profit spiraled down by -98.77%.A decline of 121.02 millions was observed in the OP in the quarter ended March 2023 from 134.54 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202203 202103 % Var
Sales 1329.75 1343.94 -1.06 4996.47 5111.86 -2.26 5111.86 3925.18 30.23
Other Income -20.62 6.41 -421.68 9.12 15.08 -39.52 15.08 24.04 -37.27
PBIDT 121.02 134.54 -10.05 240.84 368.20 -34.59 368.21 204.24 80.28
Interest 75.15 47.89 56.92 213.93 206.10 3.80 206.11 230.75 -10.68
PBDT 39.93 850.33 -95.30 20.97 925.78 -97.73 925.78 -26.51 -3592.19
Depreciation 30.73 30.02 2.37 123.84 114.51 8.15 114.50 97.54 17.39
PBT 9.20 820.31 -98.88 -102.87 811.27 -112.68 811.28 -124.05 -753.99
TAX -0.95 -5.14 -81.52 1.10 -3.47 -131.70 -3.46 2.00 -273.00
Deferred Tax -0.95 -5.14 -81.52 1.10 -3.47 -131.70 -3.46 -20.68 -83.27
PAT 10.15 825.45 -98.77 -103.97 814.74 -112.76 814.74 -126.05 -746.36
Equity 327.06 326.66 0.12 327.06 326.66 0.12 326.66 250.15 30.59
PBIDTM(%) 9.10 10.01 -9.09 4.82 7.20 -33.08 7.20 5.20 38.43

Wanbury Share Price

259.05 -6.90 (-2.59%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×